Takeda Pharmaceutical Company Limited (TKD:F) Annual Income Statement ()
TKD:F Quarterly Financials ()
Frequently Asked Questions About Takeda Pharmaceutical Company Limited (TKD:F) Stock
Takeda Pharmaceutical Company Limited's (TKD:F) last reported annual revenue was EUR 4,027.48 Billion.
Takeda Pharmaceutical Company Limited's (TKD:F) annual revenue growth rate based on the revenue reported in the past 5 years is : 17.87%
Takeda Pharmaceutical Company Limited's(TKD:F) is profitable as of its last reported annual financials.
The net profit margin for Takeda Pharmaceutical Company Limited's(TKD:F) from its laster reported year is 7.87%
The return on equity (ROE) for Takeda Pharmaceutical Company Limited's(TKD:F) from its last reported annual financials is : 2.76%
The return on assets (ROA) for Takeda Pharmaceutical Company Limited's(TKD:F) from its last reported annual financials is : 2.61%
The return on invested capital (ROIC) for Takeda Pharmaceutical Company Limited's(TKD:F) from its last reported annual financials is : 4.72%
The Debt to Equity ratio for Takeda Pharmaceutical Company Limited's(TKD:F) from its last reported annual financials is : 63.62%
The dividend yield for Takeda Pharmaceutical Company Limited's(TKD:F) from its laster reported year is 4.91%
Takeda Pharmaceutical Company Limited's(TKD:F) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TKD:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
